Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-04-04
DOI
10.3389/fpsyt.2018.00091
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of AZD3480 on Cognition in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase IIb Dose-Finding Study
- (2018) Lutz Frölich et al. JOURNAL OF ALZHEIMERS DISEASE
- Effects of memantine added to risperidone on the symptoms of schizophrenia: A randomized double-blind, placebo-controlled clinical trial
- (2017) Robabeh Mazinani et al. PSYCHIATRY RESEARCH
- Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
- (2016) Yoshiteru Takekita et al. BMC Psychiatry
- A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia
- (2016) Ragy R Girgis et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study
- (2016) S. R. T. Veerman et al. PSYCHOLOGICAL MEDICINE
- Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study
- (2016) S. R. T. Veerman et al. PSYCHOLOGICAL MEDICINE
- Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson’s Disease Patients Taking Dopaminergic Medication
- (2016) Hidetomo Murakami et al. Journal of Parkinsons Disease
- Impact of Rivastigmine on Cognitive Dysfunction and Falling in Parkinson's Disease Patients
- (2015) Zhenguang Li et al. EUROPEAN NEUROLOGY
- Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo-controlled study
- (2015) Eugenia Mamikonyan et al. MOVEMENT DISORDERS
- Raloxifene for women with Alzheimer disease
- (2015) Victor W. Henderson et al. NEUROLOGY
- Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
- (2015) Richard SE Keefe et al. NEUROPSYCHOPHARMACOLOGY
- Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia
- (2015) David Walling et al. SCHIZOPHRENIA BULLETIN
- Effect of lurasidone dose on cognition in patients with schizophrenia: Post-hoc analysis of a long-term, double-blind continuation study
- (2015) Philip D. Harvey et al. SCHIZOPHRENIA RESEARCH
- Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder
- (2014) Kamilla W. Miskowiak et al. JOURNAL OF CLINICAL PSYCHIATRY
- Inflammatory mediators of cognitive impairment in bipolar disorder
- (2014) Isabelle E. Bauer et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A Randomized, Placebo-Controlled Study Investigating the Nicotinic α7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia
- (2014) Daniel Umbricht et al. NEUROPSYCHOPHARMACOLOGY
- Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson's disease with dementia
- (2014) Chon-Haw Tsai et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis
- (2013) C. Bourne et al. ACTA PSYCHIATRICA SCANDINAVICA
- The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease
- (2013) Johanna L. Crimins et al. AGEING RESEARCH REVIEWS
- Neural Correlates of Impaired Cognitive Control over Working Memory in Schizophrenia
- (2013) Teal S. Eich et al. BIOLOGICAL PSYCHIATRY
- Benzoate, a D-Amino Acid Oxidase Inhibitor, for the Treatment of Early-Phase Alzheimer Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2013) Chieh-Hsin Lin et al. BIOLOGICAL PSYCHIATRY
- Effect of lurasidone on neurocognitive performance in patients with schizophrenia: A short-term placebo- and active-controlled study followed by a 6-month double-blind extension
- (2013) Philip D. Harvey et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effects of raloxifene on cognition in postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial
- (2013) Elena Huerta-Ramos et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: A preliminary open-label trial
- (2013) Hidenobu Suzuki et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia
- (2013) Maria Rosaria A. Muscatello et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease
- (2013) Wooyoung Jang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia
- (2013) Jeffrey A Lieberman et al. NEUROPSYCHOPHARMACOLOGY
- Pilot study of Intravenous Nicotine Effects on Cognitive Performance in Schizophrenia
- (2013) Douglas L. Boggs et al. SCHIZOPHRENIA RESEARCH
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- Proactive and reactive cognitive control and dorsolateral prefrontal cortex dysfunction in first episode schizophrenia
- (2013) Tyler A. Lesh et al. NeuroImage-Clinical
- Variability in Wechsler Adult Intelligence Scale-IV Subtest Performance Across Age
- (2012) N. M. Wisdom et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- Dopamine-Dependent Architecture of Cortico-Subcortical Network Connectivity
- (2012) D. M. Cole et al. CEREBRAL CORTEX
- Effect of Aripiprazole on Verbal Memory and Fluency in Schizophrenic Patients
- (2012) Chris Bervoets et al. CNS DRUGS
- The influence of switching from haloperidol decanoate depot to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia
- (2012) Hidenobu Suzuki et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia
- (2012) Sung-Wan Kim et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- BL-1020, a New γ-Aminobutyric Acid–Enhanced Antipsychotic
- (2012) Yona Geffen et al. JOURNAL OF CLINICAL PSYCHIATRY
- Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
- (2012) Per Svenningsson et al. LANCET NEUROLOGY
- Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study
- (2012) Jung Goo Lee et al. Psychiatry Investigation
- Deficits in Domains of Social Cognition in Schizophrenia: A Meta-Analysis of the Empirical Evidence
- (2012) Gauri N. Savla et al. SCHIZOPHRENIA BULLETIN
- A preliminary, randomized, double-blind, placebo-controlled trial of l-carnosine to improve cognition in schizophrenia
- (2012) K.N. Roy Chengappa et al. SCHIZOPHRENIA RESEARCH
- Social cognition in euthymic bipolar disorder: systematic review and meta-analytic approach
- (2011) C. Samamé et al. ACTA PSYCHIATRICA SCANDINAVICA
- Reduced Proactive Inhibition in Schizophrenia Is Related to Corticostriatal Dysfunction and Poor Working Memory
- (2011) Bram B. Zandbelt et al. BIOLOGICAL PSYCHIATRY
- Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment
- (2011) James P. Kelleher et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Acute nicotine enhances strategy-based semantic processing in Parkinson's disease
- (2011) Anna D. Holmes et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Placebo-Controlled Adjunctive Trial of Pramipexole in Patients With Bipolar Disorder
- (2011) Katherine E. Burdick et al. JOURNAL OF CLINICAL PSYCHIATRY
- Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
- (2011) Joo-Cheol Shim et al. NEUROPSYCHOPHARMACOLOGY
- Glutamate receptors in preclinical research on Alzheimer's disease: Update on recent advances
- (2011) Neng-Wei Hu et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia
- (2011) Dawn Velligan et al. SCHIZOPHRENIA RESEARCH
- Cognition in schizophrenia: core psychological and neural mechanisms
- (2011) Deanna M. Barch et al. TRENDS IN COGNITIVE SCIENCES
- Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity
- (2010) Yao Shen et al. FREE RADICAL BIOLOGY AND MEDICINE
- High dose D-serine in the treatment of schizophrenia
- (2010) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia
- (2010) Jean-Pierre Lindenmayer et al. SCHIZOPHRENIA RESEARCH
- Galantamine-ER For Cognitive Dysfunction In Bipolar Disorder and Correlation with Hippocampal Neuronal Viability: A Proof-of-Concept Study
- (2009) Dan V. Iosifescu et al. CNS Neuroscience & Therapeutics
- Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia
- (2009) David de Lucena et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Double-Blind, Placebo-Controlled Pilot Study of Galantamine to Improve Cognitive Dysfunction in Minimally Symptomatic Bipolar Disorder
- (2009) S. Nassir Ghaemi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder
- (2009) Robert C. Smith et al. SCHIZOPHRENIA RESEARCH
- A 12‐week open‐label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late‐life bipolar disorder
- (2008) Ariel G. Gildengers et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease
- (2008) J Grace et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
- (2008) Christopher C Rowe et al. LANCET NEUROLOGY
- A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia
- (2008) Jeffrey A Lieberman et al. NEUROPSYCHOPHARMACOLOGY
- A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia
- (2008) Shahin Akhondzadeh et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A placebo-controlled study of sildenafil effects on cognition in schizophrenia
- (2008) Donald C. Goff et al. PSYCHOPHARMACOLOGY
- Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia
- (2008) Kristi A. Sacco et al. SCHIZOPHRENIA RESEARCH
- A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment
- (2008) Philip D. Harvey et al. SCHIZOPHRENIA RESEARCH
- High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia
- (2008) M DYER et al. SCHIZOPHRENIA RESEARCH
- Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
- (2008) D GOFF et al. SCHIZOPHRENIA RESEARCH
- Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: An open-label trial
- (2008) Young-Chul Chung et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia
- (2007) Robert W. Buchanan et al. AMERICAN JOURNAL OF PSYCHIATRY
- Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study
- (2007) Amir Krivoy et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started